000 02061cam a2200373 i 4500
999 _c12874
_d12874
001 4034122
005 20210307103309.0
008 980826s1999 nyua b 001 0 eng
010 _a 98027750
020 _a0824702182 (alk. paper)
040 _aDLC
_cDLC
_dDLC
_erda
043 _an-us---
050 0 0 _aRM301.27
_b.P74 1999
082 0 0 _a615.19
_222
_bP.
245 0 0 _aPreparing for FDA pre-approval inspections /
_cedited by Martin D. Hynes, III.
264 1 _aNew York :
_bMarcel Dekker Inc.,
_c[1999]
264 4 _c©1999
300 _aix, 284 pages :
_billustrations ;
_c24 cm
336 _2rdacontent
_atext
337 _2rdamedia
_aunmediated
338 _2rdacarrier
_avolume
490 1 _aDrugs and the pharmaceutical sciences ;
_vv. 93
504 _aIncludes bibliographical references and index.
505 0 _aIntroduction to the Food and Drug Administration Pre-New Drug Applications Approval Inspections o Developing a Strategic Approach to Preparing for a Successful Pre-NDA Approval Inspection o Food and Drug Administration International Pre-Approval Inspections o Stability Data and Pre-Approval Inspections o Consequences of Failing a Pre-Approval Inspection o Successful Management of a Pre-Approval Inspection o The Validation of Pharmaceutical Processes o Documentation Standards for Pre-Approval Inspections o Technology Transfer and Scale-up o Training of Personnel in the Pharmaceutical Industry o Compliance with Current Good Manufacturing Practices and Application Commitments
610 1 0 _aUnited States.
_bFood and Drug Administration.
650 0 _aDrugs
_xResearch
_xStandards
_zUnited States.
700 1 _aHynes, Martin D.
_eeditor.
830 0 _tDrugs and the pharmaceutical sciences
856 4 2 _3Publisher description
_uhttp://www.loc.gov/catdir/enhancements/fy0647/98027750-d.html
906 _a7
_bcbc
_corignew
_d1
_eocip
_f19
_gy-gencatlg
942 _2ddc
_cBK